Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 961 AL 975

Susceptibility-Weighted Imaging in Neurodegenerative Disorders: A Review

Sotoudeh H, Sarrami AH, Wang JX, Saadatpour Z, Razaei A, Gaddamanugu S, Choudhary G, Shafaat O, Singhal A.

J Neuroimaging. 2021 May;31(3):459-470. doi: 10.1111/jon.12841. Epub 2021 Feb 23.

Baroreflex dysfunction in Parkinson's disease: integration of central and peripheral mechanisms

Sabino-Carvalho JL, Falquetto B, Takakura AC, Vianna LC.

J Neurophysiol. 2021 Apr 1;125(4):1425-1439. doi: 10.1152/jn.00548.2020. Epub 2021 Feb 24.

Management, Levels of Support, Quality of Life, and Social Inclusion in Parkinson's Disease: Interventions, Innovation, and Practice Development

Portillo MC, Haahr A, Navarta-Sánchez MV.

Parkinsons Dis. 2021 Jan 29;2021:4681251. doi: 10.1155/2021/4681251. eCollection 2021.

Long-term safety and efficacy of opicapone in Japanese Parkinson's patients with motor fluctuations

Takeda A, Takahashi R, Tsuboi Y, Nomoto M, Maeda T, Nishimura A, Yoshida K, Hattori N.

J Neural Transm (Vienna). 2021 Mar;128(3):337-344. doi: 10.1007/s00702-021-02315-1. Epub 2021 Feb 25.

Novel targeted therapies for Parkinson's disease

Ntetsika T, Papathoma PE, Markaki I.

Mol Med. 2021 Feb 25;27(1):17. doi: 10.1186/s10020-021-00279-2.

Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies

Zhang JF, Wang XX, Feng Y, Fekete R, Jankovic J, Wu YC.

Front Psychiatry. 2021 Feb 9;12:635494. doi: 10.3389/fpsyt.2021.635494. eCollection 2021.

Glycoproteins as diagnostic and prognostic biomarkers for neurodegenerative diseases: A glycoproteomic approach

Xu MM, Zhou MT, Li SW, Zhen XC, Yang S.

J Neurosci Res. 2021 May;99(5):1308-1324. doi: 10.1002/jnr.24805. Epub 2021 Feb 26.

Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease

Kakoty V, K C S, Dubey SK, Yang CH, Kesharwani P, Taliyan R.

Neurosci Lett. 2021 Apr 17;750:135769. doi: 10.1016/j.neulet.2021.135769. Epub 2021 Feb 23.

Association of lipid levels with motor and cognitive function and decline in advanced Parkinson's disease in the Mark-PD study

Choe CU, Petersen E, Lezius S, Cheng B, Schulz R, Buhmann C, Pötter-Nerger M, Daum G, Blankenberg S, Gerloff C, Schwedhelm E, Zeller T.

Parkinsonism Relat Disord. 2021 Apr;85:5-10. doi: 10.1016/j.parkreldis.2021.02.007. Epub 2021 Feb 17.

Excessive daytime sleepiness in Parkinson's disease: A systematic review and meta-analysis

Feng F, Cai Y, Hou Y, Ou R, Jiang Z, Shang H.

Parkinsonism Relat Disord. 2021 Apr;85:133-140. doi: 10.1016/j.parkreldis.2021.02.016. Epub 2021 Feb 16.

Region-specific vulnerability in neurodegeneration: lessons from normal ageing

Pandya VA, Patani R.

Ageing Res Rev. 2021 May;67:101311. doi: 10.1016/j.arr.2021.101311. Epub 2021 Feb 24.

Anglo-French neurological interactions in the 19th and early 20th centuries: Physicians, places and events

Broussolle E, Reynolds EH.

Rev Neurol (Paris). 2021 Oct;177(8):859-870. doi: 10.1016/j.neurol.2020.10.013. Epub 2021 Feb 25.

Cardiolipin, Mitochondria, and Neurological Disease

Falabella M, Vernon HJ, Hanna MG, Claypool SM, Pitceathly RDS.

Trends Endocrinol Metab. 2021 Apr;32(4):224-237. doi: 10.1016/j.tem.2021.01.006. Epub 2021 Feb 24.

Social cognition in Parkinson's disease

Lewis SJG, Ricciardi L.

Parkinsonism Relat Disord. 2021 Apr;85:122-123. doi: 10.1016/j.parkreldis.2021.02.024. Epub 2021 Feb 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias